Charming Medical Limited
Case Overview
| Lead Plaintiff Deadline: | Lead Plaintiff Deadline: 02/17/2026 |
| Status: | Status: Investigating |
| Company Name: | Company Name: Charming Medical Limited |
| Court: | Court: Southern District of New York |
| Case Number: | Case Number: 1:25cv10535 |
| Class Period: | Class Period: 10/10/2025 - 11/12/2025 |
| Ticker: | Ticker: MCTA |
| Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
| Related Practices: | Related Practices: Securities |
Charming is a medical company that claims to "enhance the quality of life from the inside out by integrating Traditional Chinese Medicine (TCM) wellness practices with modern technology." Specifically, by "combining customized TCM-inspired constitution-regulating plans and modern wellness therapies, we provide comprehensive wellness and beauty services and products for women and TCM-inspired therapies tailored for men." The Company's stock trades on NASDAQ under the symbol "MCTA." The complaint alleges that Defendants violated provisions of the Securities Act arising from the suspension of Charming's stock in November 2025, following a dramatic yet illusory run-up orchestrated by a fraudulent stock promotion scheme. In the weeks leading up to November 12, 2025, Charming's share price surged from the initial public offering price ("IPO") of $4.00 to an all-time high of $29.36 per share, despite no fundamental news from the Company justifying such a spike. Investigations and public reports have revealed that Charming's stock became the subject of an illicit social-media-based promotion scheme that artificially inflated its price. These reports detail how impersonators claiming to be legitimate financial advisors touted Charming in online forums, chat groups, and through social media posts with sensational, but baseless, claims to create a buying frenzy among retail investors.